China (Mainland)
BMS-986165 CAS NO.1609392-27-9
- FOB Price: USD: 100.00-100.00 /Metric Ton Get Latest Price
- Min.Order: 1 Gram
- Payment Terms: T/T
- Available Specifications:
Medical Grade(1-2)Metric Ton
- Product Details
Keywords
- BMS-986165
- BMS-986165 99.5%
- BMS
Quick Details
- ProName: BMS-986165
- CasNo: 1609392-27-9
- Application: Chinese name: BMS-986165 Chines...
- PackAge: 10
- Port: Shanghai port
- ProductionCapacity: 20 Metric Ton/Day
- Purity: 99%
- LimitNum: 1 Gram
Superiority
Chinese name: BMS-986165
Chinese synonym: compound BMS-986165; BMS-986165; BMS986165; BMS986165; DEUCRAVACITINIB
English name: BMS-986,165
English synonym: BMS-986165; Tyk2-IN-4; TYK2-IN-4; BMS986165; BMS-986165; BMS986165; 6-(cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)-N-(methyl-d3)pyridazine-3-carboxamide; Deucravacitinib; Deucravacitinib(BMS986165); Deucravacitinib(TYK2-IN-4;6-cyclopropaneamido-4-{[2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl]amino}-N-(2H )methylpyridazine-3-carboxamide
CAS No.: 1609392-27-9
Molecular formula: C20H22N8O3
Molecular weight: 422.45EINECS No.:
Related categories: new products; Inhibitors; Pharmaceutical and chemical raw materials; Fine chemical products; Standards; Pharmaceutical raw materials; Belka; API; APIS; APIMol file: 1609392-27-9.molBMS-986165 Property: BMS-986165
Application and synthesis method
Purposes BMS-986,165 is a new type of oral selective TYK2 inhibitor. Its unique mechanism of action is expected to provide a promising oral choice to help patients effectively control their psoriasis.
The bioactive Deucravacitinib (BMS-986165) is a powerful and selective allosteric inhibitor of Tyk2. The Ki value of its binding to the pseudo kinase domain of Tyk2 is 0.02 nM. It is highly selective for a group of 265 kinases and pseudokinases. TargetValueTyk2 (Cell freeassay) 0.02nM
Details
Chinese name: BMS-986165
Chinese synonym: compound BMS-986165; BMS-986165; BMS986165; BMS986165; DEUCRAVACITINIB
English name: BMS-986,165
English synonym: BMS-986165; Tyk2-IN-4; TYK2-IN-4; BMS986165; BMS-986165; BMS986165; 6-(cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)-N-(methyl-d3)pyridazine-3-carboxamide; Deucravacitinib; Deucravacitinib(BMS986165); Deucravacitinib(TYK2-IN-4;6-cyclopropaneamido-4-{[2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl]amino}-N-(2H )methylpyridazine-3-carboxamide
CAS No.: 1609392-27-9
Molecular formula: C20H22N8O3
Molecular weight: 422.45EINECS No.:
Related categories: new products; Inhibitors; Pharmaceutical and chemical raw materials; Fine chemical products; Standards; Pharmaceutical raw materials; Belka; API; APIS; APIMol file: 1609392-27-9.molBMS-986165 Property: BMS-986165
Application and synthesis method
Purposes BMS-986,165 is a new type of oral selective TYK2 inhibitor. Its unique mechanism of action is expected to provide a promising oral choice to help patients effectively control their psoriasis.
The bioactive Deucravacitinib (BMS-986165) is a powerful and selective allosteric inhibitor of Tyk2. The Ki value of its binding to the pseudo kinase domain of Tyk2 is 0.02 nM. It is highly selective for a group of 265 kinases and pseudokinases. TargetValueTyk2 (Cell freeassay) 0.02nM